8 employees
Seneca is a biotechnology company that focuses on developing novel oncolytic immunotherapeutics for the treatment of cancer.
2018
Seneca Therapeutics, Inc. raised undisclosed on May 4, 2021
Investors: Mid Atlantic Bio Angels and Keiretsu Capital
Seneca Therapeutics, Inc. raised undisclosed on January 20, 2021
Investors: Broad Street Angels and Keiretsu Capital